Late reactivation of resolved hepatitis B virus infection: An increasing complication post rituximab-based regimens treatment?

被引：52

作者：

Garcia-Rodriguez, Maria J. ^{[1
]}

Canales, Miguel A. ^{[1
,2
]}

Hernandez-Maraver, Dolores ^{[1
]}

Hernandez-Navarro, Fernando ^{[1
,2
]}

机构：

[1] Hosp Univ La Paz, Serv Hematol, Madrid 28046, Spain

[2] Univ Autonoma Madrid, Dept Med, E-28049 Madrid, Spain

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2008年 / 83卷 / 08期

关键词：

D O I：

10.1002/ajh.21214

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Reactivation of hepatitis B infection is an increasing problem for patients with lymphoma, even in resolved infections, who were treated with rituximab-based regimens. Our cases point out the need of prolonged prophylaxis in HBsAg-negative patients due to the high risk of developing fatal reactivation.

引用

页码：673 / 675

页数：3

共 23 条

[1] Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. [J].

Dervite, I ;

Hober, D ;

Morel, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :68-69

[2]

Firpi Roberto J, 2006, Hematology Am Soc Hematol Educ Program, P375

[3] Incidence of hepatitis B reactivation in association with rituximab therapy. [J].

Hanbali, Amr ;

Khaled, Yasser ;

Ajrouche, Hussein ;

Ansari, Shan ;

Janakiraman, Nalini .

BLOOD, 2006, 108 (11) :783A-783A

[4] Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy [J].

Idilman, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) :828-831

[5] Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy [J].

Lau, GKK ;

Yiu, HHY ;

Fong, DYT ;

Cheng, HC ;

Au, WY ;

Lai, LSF ;

Cheung, M ;

Zhang, HY ;

Lie, A ;

Ngan, R ;

Liang, R .

GASTROENTEROLOGY, 2003, 125 (06) :1742-1749

[6] Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations [J].

Law, JK ;

Ho, JK ;

Hoskins, PJ ;

Erb, SR ;

Steinbrecher, UP ;

Yoshida, EM .

LEUKEMIA & LYMPHOMA, 2005, 46 (07) :1085-1089

[7] Chronic hepatitis B: Update of recommendations [J].

Lok, ASF ;

McMahon, BJ .

HEPATOLOGY, 2004, 39 (03) :857-861

[8] Hepatitis B virus reactivation after cytotoxic chemotherapy: The disease and its prevention [J].

Mindikoglu, Ayse L. ;

Regev, Arie ;

Schiff, Eugene R. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (09) :1076-1081

[9] Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy [J].

Niscola, P ;

Del Principe, MI ;

Maurillo, L ;

Venditti, A ;

Buccisano, F ;

Piccioni, D ;

Amadori, S ;

Del Poeta, G .

LEUKEMIA, 2005, 19 (10) :1840-1841

[10] Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma [J].

Ozguroglu, M ;

Bilici, A ;

Turna, H ;

Serdengecti, S .

MEDICAL ONCOLOGY, 2004, 21 (01) :67-72

← 1 2 3 →